A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease

European Journal of Human Genetics

Volumn 20, Issue 6, 2012, Pages 613-617

  Rovelet Lecrux, Anne ^a,b   Legallic, Solenn ^a,b   Wallon, David ^a,b   Flaman, Jean Michel ^a   Martinaud, Olivier ^a,b   Bombois, Stéphanie ^b,c   Rollin Sillaire, Adeline ^b,c   Michon, Agnès ^b,d   Le Ber, Isabelle ^b,d   Pariente, Jérémie ^e   Puel, Michèle ^e   Paquet, Claire ^f   Croisile, Bernard ^g   Thomas Antérion, Catherine ^h   Vercelletto, Martine ⁱ   Lévy, Richard ^j   Frébourg, Thierry ^a   Hannequin, Didier ^a,b   Campion, Dominique ^a,b,k  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIV LILLE   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e CHU PURPAN   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g CHU   (France)

^h CMRR   (France)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j HÔPITAL SAINT ANTOINE   (France)

^k CH Rouvray   (France)

more..

Author keywords

Alzheimer disease; copy number variations; FPR2; KLK6; MEOX2; SLC30A3

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DNA; PRESENILIN 1; PRESENILIN 2;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; FAMILY STUDY; GENE MUTATION; GENETIC ASSOCIATION; GENOME; HUMAN; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; DNA COPY NUMBER VARIATIONS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

ANIMALIA;

EID: 84861202762     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.225     Document Type: Article

References (19)

1. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356. (Pubitemid 34790756)
2. Campion D, Dumanchin C, Hannequin D et al.Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 1999; 65: 664-670. (Pubitemid 30468710)
3. Raux G, Guyant-Marechal L, Martin C et al. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet 2005; 42: 793-795. (Pubitemid 41475257)
4. Rovelet-Lecrux A, Hannequin D, Raux G,et al.APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006; 38: 24-26. (Pubitemid 43011878)
5. Lupski JR: Genomic rearrangements and sporadic disease. Nat Genet 2007; 39: S43-S47. (Pubitemid 47014475)
6. Heinzen EL, Need AC, Hayden KM,et al.Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis 2010; 19: 69-77.
7. Swaminathan S, Kim S, Shen L,et al.Genomic copy number analysis in Alzheimer's disease and mild cognitive impairment: an ADNI study. Int J Alzheimers Dis 2011; 2011: 729478.
8. McKhann G, Drachman D, Folstein M,et al.Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
9. Charbonnier F, Raux G, Wang Q,et al.Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000; 60: 2760-2763. (Pubitemid 30395787)
10. Salminen A, Ojala J, Suuronen T, Kaarniranta K, Kauppinen A: Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J CellMolMed 2008; 12: 2255-2262.
11. Ogawa K, Yamada T, Tsujioka Y,et al.Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease. Psychiatry Clin Neurosci 2000; 54: 419-426.
12. Little SP, Dixon EP, Norris F,et al.Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J Biol Chem1997; 272: 25135-25142. (Pubitemid 27415697)
13. Wu Z, Guo H, Chow N,et al.Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 2005; 11: 959-965. (Pubitemid 41294441)
14. Friedlich AL, Lee JY, van Groen T,et al.Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J Neurosci 2004; 24: 3453-3459. (Pubitemid 38451911)
15. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J: A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J Neurosci 2009; 29: 4004-4015.
16. Iribarren P, Zhou Y, Hu J, Le Y, Wang JM: Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol Res 2005; 31: 165-176. (Pubitemid 40628955)
17. Tiffany HL, Lavigne MC, Cui YH,et al.Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem 2001; 276: 23645-23652.
18. Ying G, Iribarren P, Zhou Y,et al.Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 2004; 172: 7078-7085. (Pubitemid 38669150)
19. Cirulli ET, Goldstein DB: Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010; 11: 415-425.